Healthcare -
Biotechnology - NASDAQ - US
$ 1.95
-7.14 %
$ 104 M
Market Cap
-2.05
P/E
TCRX - COST OF REVENUE
Cost of Revenue TCRX - TScan Therapeutics, Inc.
88.2 M
LAST VALUE
414.67%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR